Analysed TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) News Sources
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
29-04-2026
yahoo.com
Telix Pharmaceuticals Webinar Highlights Next-Gen PSMA Therapy, OPTIMAL-PSMA Enrollment Nears End
30-04-2026
marketbeat.com
How TLX597-Tx Phase 2 Dosimetry Data Will Impact Telix Pharmaceuticals (ASX:TLX) Investors
30-04-2026
yahoo.com
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
04-05-2026
yahoo.com
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
15-05-2026
yahoo.com
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
18-05-2026
yahoo.com
What is the current price of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The current price of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is $9.56.
TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) since the previous trading day is $-0.18.
TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) since the previous trading day is -1.848%.
What is the most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The most recent average sentiment score for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)?
The most recent sentiment for TELIX PHARMACEUTICALS LTD (TLX:NASDAQ) is .
SEC-8K** Filing Available For TELIX PHARMACEUTICALS LTD (TLX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.